Your browser doesn't support javascript.
loading
Clonal Neoantigen: Emerging "Mechanism-based" Biomarker of Immunotherapy Response.
Nemunaitis, John; Stanbery, Laura; Willoughby, David; Bognar, Ernest; Brun, Scott; Walter, Adam; Monk, Bradley J; Rocconi, Rodney P; Choucair, Khalil; Coleman, Robert L.
Afiliación
  • Nemunaitis J; Gradalis, Inc., Dallas, TX 75225, USA.
  • Stanbery L; Gradalis, Inc., Dallas, TX 75225, USA.
  • Willoughby D; Frontage Laboratories Inc., Deerfield Beach, FL 33442, USA.
  • Bognar E; Gradalis, Inc., Dallas, TX 75225, USA.
  • Brun S; Gold Mast Consulting, LLC, The Woodlands, TX 77380, USA.
  • Walter A; Gradalis, Inc., Dallas, TX 75225, USA.
  • Monk BJ; HonorHealth Research Institute, College of Medicine, University of Arizona, Phoenix, AZ 85012, USA.
  • Rocconi RP; School of Medicine, Creighton University, Phoenix, AZ 85012, USA.
  • Choucair K; University of Mississippi Medical Center, Jackson, MS 39216, USA.
  • Coleman RL; Department of Medical Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.
Cancers (Basel) ; 15(23)2023 Nov 28.
Article en En | MEDLINE | ID: mdl-38067319
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos